Source comparison
Mechanism of Action: PE-22-28 vs Selank Amidate
PE-22-28 is a synthetic 15-amino-acid sequence derived from ciliary neurotrophic factor (CNTF), designed to cross the blood-brain barrier more efficiently than full-length CNTF while retaining its neurotrophic signaling capacity. Once in the CNS, PE-22-28 bind
This comparison does not assign a generated winner or score.
- PE-22-28 is a synthetic 15-amino-acid sequence derived from ciliary neurotrophic factor (CNTF), designed to cross the blood-brain barrier more efficiently than full-length CNTF while retaining its neurotrophic signaling capacity. Once in the CNS, PE-22-28 binds to gp130 receptors on neurons and glial cells, triggering the JAK-STAT3 pathway. The same cascade activated by endogenous BDNF. This initiates transcription of genes involved in synaptic plasticity, dendritic arborization, and neuroprotection against oxidative stress. Studies in hippocampal slice cultures show PE-22-28 administration increases dendritic spine density by 22–30% over 14-day exposure windows, with corresponding improvements in long-term potentiation (LTP) duration.
- Selank Amidate. The acetylated variant of the heptapeptide Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro). Works through an entirely different mechanism. The amidate modification (acetylation at the C-terminus) extends plasma half-life from approximately 20 minutes to 4–6 hours by preventing enzymatic degradation. Selank Amidate doesn't cross the BBB in significant concentrations; instead, it modulates peripheral and central stress pathways by inhibiting enkephalin-degrading enzymes (neprilysin, aminopeptidase N), which increases endogenous enkephalin levels. Elevated enkephalins enhance GABAergic inhibition in the amygdala and prefrontal cortex, reducing corticotropin-releasing hormone (CRH) output and blunting the HPA axis response to acute stressors. Behaviorally, this manifests as reduced anxiety-like behavior in elevated plus maze and open field tests within 48–72 hours.
- The critical distinction: PE-22-28 alters the structural substrate of cognition. It builds synaptic infrastructure. Selank Amidate modulates the neurochemical environment during stress but doesn't change baseline neural architecture. You can't substitute one for the other in a protocol designed around the other's mechanism.